Key Insights

Highlights

Treatment Research

3 treatments under study, led by No Intervention Observational Cohort

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown2
Active Not Recruiting1
Not Yet Recruiting1

Clinical Trials (4)

Research Network

Common Treatments

  • No Intervention Observational Cohort1
  • Cade System1
  • Endomicroscopy Targeted Biopsy And 16s Rrna Gene Sequencing1

Active Sponsors

  • Shandong University2
  • Fudan University1
  • Chinese University of Hong Kong1

Top Investigators

Related Conditions

  • Hpylori1
  • Intestinal Metaplasia1
  • Mucosal Microbiome1

Activity Timeline